about
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a ...
Read More
9.14
0.15
(1.67%)
608.1K
XNAS Volume
XNAS 17 Nov, 2025 1:17 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Replimune Group Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..